Skip to main content
HairCited

Dutasteride के लिए Androgenetic Alopecia

A

43 अध्ययनों (7 meta-analyses, 1 RCT) पर आधारित, में कुल 12,060 प्रतिभागियों के साथ। 34/43 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Ddutasteride\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Dutasteride has strong scientific support for androgenetic alopecia and research suggests it may be more effective than finasteride, though it should be used under medical supervision due to potential side effects.

  • 34 out of 43 studies show positive effects across 12,060 participants
  • Multiple meta-analyses consistently support dutasteride's effectiveness for pattern hair loss
  • Blocks both type I and type II 5-alpha reductase enzymes, potentially offering broader DHT reduction than finasteride
  • Available in both oral and topical formulations, with topical forms being actively researched

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: women with androgenetic alopecia (female pattern hair loss)

Randomized Controlled Trial n=139 24 weeks Double-blind
Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, …
Dose: 0.2 mg dutasteride daily बनाम: Placebo; 0.5 mg dutasteride daily Outcome: Change in hair count at vertex from baseline प्रभाव: 21.53 vs 5.96 hair count increase 0.0072

जनसंख्या: Men with androgenetic alopecia

Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) बनाम: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment प्रभाव: None None

जनसंख्या: Adult males with androgenetic alopecia

Other n=20 8 weeks Open-label
Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic …
Dose: 4 monthly sessions of SPi + iontophoresis बनाम: Baseline (pre-post design, no control) Outcome: Hair density, shaft diameter, pull test at 8 … प्रभाव: None <0.001 (density, diam, pull)

जनसंख्या: 10 males + 10 postmenopausal females with resistant AGA

Review
Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review.
Dose: Dutasteride (oral, various doses) बनाम: Placebo प्रभाव: None None
Review
Male and female pattern hair loss.
Dose: None बनाम: Placebo प्रभाव: None None

Key Statistics

99

अध्ययन

19921

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Therapeutic delivery 2025 4 उद्धरण
Journal of cosmetic … 2025 3 उद्धरण
Australian prescriber 2025 2 उद्धरण
Journal of cutaneous … 2025 2 उद्धरण
Journal of clinical … 2025 1 उद्धरण
Annals of dermatology 2025
Biomedicines 2024 17 उद्धरण
Dermatology (Basel, Switzerland) 2024 14 उद्धरण
Journal of cosmetic … 2024 11 उद्धरण
Facial plastic surgery … 2024 8 उद्धरण
Journal of cosmetic … 2024 8 उद्धरण
American journal of … 2023 41 उद्धरण
Dermatology and therapy 2023 23 उद्धरण
Dermatologic surgery : … 2023 2 उद्धरण
Dermatologic therapy 2022 14 उद्धरण
Fertility and sterility 2020 94 उद्धरण
Neurobiology of stress 2020 72 उद्धरण
General and comparative … 2020 37 उद्धरण
Facial plastic surgery … 2020 15 उद्धरण
Alternative therapies in … 2020 11 उद्धरण
Archivos espanoles de … 2020 1 उद्धरण
Journal of the … 2019 95 उद्धरण
Journal of the … 2019 55 उद्धरण
The aging male … 2019 19 उद्धरण
Assay and drug … 2019 19 उद्धरण
Expert opinion on … 2018 38 उद्धरण
Current clinical pharmacology 2017 62 उद्धरण
International journal of … 2017 45 उद्धरण
Actas dermo-sifiliograficas 2017 17 उद्धरण
The Cochrane database … 2016 18 उद्धरण
Indian journal of … 2016 8 उद्धरण
Current problems in … 2015 8 उद्धरण
Expert opinion on … 2014 57 उद्धरण
Current opinion in … 2014 43 उद्धरण
Dermatologic clinics 2013 78 उद्धरण
Journal of cosmetic … 2013 62 उद्धरण
Facial plastic surgery … 2013 16 उद्धरण
International journal of … 2013
Skin therapy letter 2012 100 उद्धरण
Expert opinion on … 2010 264 उद्धरण
Current opinion in … 2009 54 उद्धरण
Seminars in cutaneous … 2009 4 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

hairloss:
0.5 mg/day (off-label)

अधिकतम सीमा: 0.5 mg/day

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Neutral --
0.2 mg dutasteride daily 24 weeks Positive 139
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
4 monthly sessions of SPi + iontophoresis 8 weeks Positive 20
Dutasteride (oral, various doses) -- Positive --
None -- Positive --
None -- Positive --
None -- Positive --

सेवन का सर्वोत्तम समय: Once daily at the same time, with or without food; prescription required

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Decreased libido (more common than finasteride)
  • Erectile dysfunction
  • Ejaculation disorders
  • Gynecomastia (breast tissue growth)
  • Very long half-life (~5 weeks) means slow side effect resolution

ज्ञात अंतःक्रियाएँ

  • CYP3A4 inhibitors (ketoconazole, ritonavir) may increase dutasteride levels
  • May affect PSA levels (reduces by ~50%)
  • Contraindicated in pregnancy (Category X teratogen)

सहनीय अधिकतम सेवन: 0.5 mg/day

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Dutasteride help with Androgenetic Alopecia?
Based on 99 studies with 19,921 participants, there is strong evidence from multiple clinical trials that Dutasteride may support Androgenetic Alopecia management. Our evidence grade is A (Strong Evidence).
How much Dutasteride should I take for Androgenetic Alopecia?
Studies have used various dosages. A commonly studied range is 0.5 mg/day (off-label). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Dutasteride?
Reported side effects may include Decreased libido (more common than finasteride), Erectile dysfunction, Ejaculation disorders, Gynecomastia (breast tissue growth). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Dutasteride and Androgenetic Alopecia?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 99 peer-reviewed studies with 19,921 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Androgenetic Alopecia

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।